Effect of carbidopa on the metabolism of L-dopa in the pigtail monkey.
作者信息
Bronaugh R L, Wenger G R, Garver D L, Rutledge C O
出版信息
Biochem Pharmacol. 1976 Jul 15;25(14):1679-81. doi: 10.1016/0006-2952(76)90483-4.
PMID:821489
Abstract
摘要
相似文献
1
Effect of carbidopa on the metabolism of L-dopa in the pigtail monkey.
Biochem Pharmacol. 1976 Jul 15;25(14):1679-81. doi: 10.1016/0006-2952(76)90483-4.
2
[Effect of VB6 on L-DOPA decarboxylase activity in the organs of rats given peripheral L-DOPA decarboxylase inhibitors (author's transl)].
Nihon Ronen Igakkai Zasshi. 1978 Nov;15(6):566-73. doi: 10.3143/geriatrics.15.566.
3
Effect of pyridoxine on the depletion of tissue pyridoxal phosphate by carbidopa.
Metabolism. 1978 Jul;27(7):771-9. doi: 10.1016/0026-0495(78)90211-1.
4
Protective effects of L-dopa and carbidopa combined treatments on human catecholaminergic cells.左旋多巴和卡比多巴联合治疗对人儿茶酚胺能细胞的保护作用。
DNA Cell Biol. 2012 Nov;31(11):1572-9. doi: 10.1089/dna.2011.1546. Epub 2012 Sep 28.
5
The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats.
Mov Disord. 1988;3(2):117-25. doi: 10.1002/mds.870030203.
6
A comparison of the effects of decarboxylase inhibitors on L-dopa-induced circling behavior and the conversion of dopa to dopamine in the brain.
Life Sci. 1976 Sep 1;19(5):701-6. doi: 10.1016/0024-3205(76)90167-3.
7
Chronic administration does not alter the pharmacokinetic profile of L-dopa in the rat.
J Pharm Pharmacol. 1993 Aug;45(8):725-30. doi: 10.1111/j.2042-7158.1993.tb07097.x.
8
Transamination is a major pathway of L-dopa metabolism following peripheral decarboxylase inhibition.
Nature. 1974 Feb 8;247(5440):364-6. doi: 10.1038/247364b0.
9
Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.脱羧酶抑制作用以及多巴和3 - O - 甲基多巴水平：苄丝肼与卡比多巴在啮齿动物中的对比研究以及美多芭标准制剂与美多芭HBS在志愿者中的对比研究。
Eur Neurol. 1987;27 Suppl 1:9-20. doi: 10.1159/000116170.
10
The effect of L-dopa with and without decarboxylase inhibitor on growth hormone secretion in children with short stature.
Acta Paediatr Scand. 1977 Jan;66(1):81-4. doi: 10.1111/j.1651-2227.1977.tb07811.x.
引用本文的文献
1
Clinical pharmacokinetics of anti-parkinsonian drugs.抗帕金森病药物的临床药代动力学
Clin Pharmacokinet. 1987 Sep;13(3):141-78. doi: 10.2165/00003088-198713030-00002.
Zotero 插件